Records containing: Malaria
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-06-06Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents To Reduce Malaria Incidence In Military Personnel On Active Duty In Regions Of Hyperendemicity
-
CLINICAL_TRIALS study record update · 2017-05-22Computerized Cognitive Rehabilitation in Children After Severe Malaria
-
CLINICAL_TRIALS study record update · 2017-05-15Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
-
CLINICAL_TRIALS study record update · 2017-05-15Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis
-
CLINICAL_TRIALS study record update · 2017-05-11In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy in Kisumu County, Western Kenya
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-05-09The Sero-prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands
-
CLINICAL_TRIALS study record update · 2017-05-08A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Vivax Malaria Vaccine Candidates ChAd63 PvDBP Alone and With MVA PvDBP
-
CLINICAL_TRIALS study record update · 2017-04-25Bridging Safety & Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years
-
CLINICAL_TRIALS study record update · 2017-04-25Adjuvant Justification Study of Candidate Malaria Vaccines (257049), Administered According to a 0, 1, 2 Months Schedule .
-
CLINICAL_TRIALS study record update · 2017-04-20Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection
-
CLINICAL_TRIALS study record update · 2017-04-07Surveillance for the Effectiveness and Safety of Artemether-lumefantrine in Pediatric and Adult Patients With Malaria
-
CLINICAL_TRIALS study record update · 2017-03-22Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension. - A Single Oral Dose Study to Investigate Pharmacokinetics of Atovaquone and Proguanil From Combination Tablets and Atovaquone From Atovaquone Suspension in Japanese Healthy Males. -
-
CLINICAL_TRIALS study record update · 2017-03-22A Phase II, Open Label, Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Intravenous Artesunate in Adults With Uncomplicated Malaria
-
CLINICAL_TRIALS study record update · 2017-03-07A Randomized, Placebo-controlled, Double-blind Trial Using Dihydroartemisinine+Piperaquine (DP) to Protect Forest Workers From Malaria in Bu Gia Map National Park
-
CLINICAL_TRIALS study record update · 2017-03-06Intermittent Screening and Treatment (IST) or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-02-10Comparison of Two Strategies for the Delivery of Intermittent Preventive Treatment in Children (IPTc) in an Area of Seasonal Malaria Transmission
-
CLINICAL_TRIALS study record update · 2017-02-10The Extended Observation Over a Period of 28 Days of the Effects of Single Doses of OZ439 on the Recrudescence of Plasmodium Falciparum Malaria - a PhIIa, Open Label Study in Adult Patients
-
CLINICAL_TRIALS study record update · 2017-02-08A Single Centre, Two-part, Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2017-02-08A Randomized Controlled Trial on Supervised Primaquine Use in Ethiopia
-
CLINICAL_TRIALS study record update · 2017-02-06Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
-
CLINICAL_TRIALS study record update · 2017-02-01A Study to Assess Current Standard Malaria Treatment Guidelines and Evaluate Recently Developed G6PD Diagnostic Tools in the Republic of the Sudan
-
CLINICAL_TRIALS study record update · 2017-02-01Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers - a Single-center, Open-label Pharmacokinetics Study
-
CLINICAL_TRIALS study record update · 2017-01-30Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Kolokani Circle, Koulikoro Region, Mali, August-November 2016: Interventional Matched-pair Clustered Cohort
-
CLINICAL_TRIALS study record update · 2017-01-26The Effect of Malaria on Disease Progression of HIV/AIDS in Kumasi, Ghana
-
CLINICAL_TRIALS study record update · 2017-01-26Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Uncomplicated Malaria and in 2-10 Month Old Asymptomatic Infants.